Back
Calvert US Mid-Cap Core Responsible Index ETF Vs. Cidara Therapeutics Industry Stock Comparison
Buy
83
CVMC
Calvert US Mid-Cap Core Responsible Index ETF
Last Price:
$61.50
Seasonality Move:
1.81%
Buy
83
CDTX
Cidara Therapeutics
Last Price:
$50.88
Seasonality Move:
0.55%
Buy
83
Calvert US Mid-Cap Core Responsible Index ETF (CVMC)
is a Buy
Is Calvert US Mid-Cap Core Responsible Index ETF a Buy, Sell or Hold?
-
The current Calvert US Mid-Cap Core Responsible Index ETF [CVMC] share price is $61.49. The Score for CVMC is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
-
CVMC is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
83
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $50.45. The Score for CDTX is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
CVMC Stock Price Chart
What is Calvert US Mid-Cap Core Responsible Index ETF's stock price today?
-
The Calvert US Mid-Cap Core Responsible Index ETF share price today is $61.49Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVMC is experiencing selling pressure, which indicates risk of future bearish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $50.45Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CVMC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.74 | Buy |
| Relative Strength Index (14 RSI): | 64.52 | Buy |
| Chaikin Money Flow: | -2891 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.24 - 60.94) | Buy |
| Bollinger Bands (100): | (55.28 - 60.64) | Buy |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.06 | Buy |
| Relative Strength Index (14 RSI): | 78.48 | Buy |
| Chaikin Money Flow: | 1068479 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.14 - 46.86) | Buy |
| Bollinger Bands (100): | (16.26 - 33.4) | Buy |
CVMC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.15 | Buy |
| 20-day SMA: | 60.24 | Buy |
| 50-day SMA: | 59.03 | Buy |
| 200-day SMA: | 59.54 | Buy |
| 8-day EMA: | 61.14 | Buy |
| 20-day EMA: | 60.41 | Buy |
| 50-day EMA: | 59.28 | Buy |
| 200-day EMA: | 58.48 | Buy |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.83 | Buy |
| 20-day SMA: | 37.16 | Buy |
| 50-day SMA: | 28.26 | Buy |
| 200-day SMA: | 21.03 | Buy |
| 8-day EMA: | 47.24 | Buy |
| 20-day EMA: | 40.11 | Buy |
| 50-day EMA: | 31.72 | Buy |
| 200-day EMA: | 22.83 | Buy |
Calvert US Mid-Cap Core Responsible Index ETF Earnings Growth & CVMC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
Calvert US Mid-Cap Core Responsible Index ETF Technical Analysis
| Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics Technical Analysis
| Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||